Featured Research

from universities, journals, and other organizations

MRI identifies primary endometrial and cervical cancer

Date:
May 3, 2011
Source:
American Roentgen Ray Society
Summary:
MRI can determine if a patient has endometrial versus cervical cancer even when a biopsy can't make that distinction, according to a new study. Determining the primary site of a tumor helps determine appropriate cancer treatment.

MRI can determine if a patient has endometrial versus cervical cancer even when a biopsy can't make that distinction, according to a new study. Determining the primary site of a tumor helps determine appropriate cancer treatment.

The study, which is being presented during the American Roentgen Ray Society Annual Meeting on May 3 in Chicago, found that radiologists using MRI could correctly identify the primary site of cancer in 79% of cases (38/48 patients) when biopsy results are inconclusive.

Endometrial and cervical cancers are common cancers in women, said Heather He, MD/PhD, of MD Anderson Cancer Center in Houston, where the study was conducted under the direction of Dr. Iyer and Dr. Bhosale. "In about 3% of the cases, there is difficulty determining the primary cancer site," she added. "Knowing the primary cancer site means that we can give the patients the most appropriate therapy and save some patients from unnecessary surgery," Dr. He said.

Two radiologists read the images as part of the study -- one with five years experience and one with 18. Their diagnoses matched most of the time, which means that the readers' experience didn't have much of an impact on the study results, said Dr. He. "MRI can be applied on a broader scope; you don't have to have someone on staff with extensive experience to be able to offer this imaging service," she said.

The study also examined various MR sequences to determine which one was the most useful in making a diagnosis. "We found that sagittal T2 FSE weighted sequences and 2D and 3D T1 weighted dynamic enhanced sequences are the most helpful," Dr. He said.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "MRI identifies primary endometrial and cervical cancer." ScienceDaily. ScienceDaily, 3 May 2011. <www.sciencedaily.com/releases/2011/05/110503080958.htm>.
American Roentgen Ray Society. (2011, May 3). MRI identifies primary endometrial and cervical cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/05/110503080958.htm
American Roentgen Ray Society. "MRI identifies primary endometrial and cervical cancer." ScienceDaily. www.sciencedaily.com/releases/2011/05/110503080958.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins